Rock Springs Capital Management LP Ngm Biopharmaceuticals Inc Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$15.06 - $30.03 $5.49 Million - $11 Million	-364,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $107,457 - $137,299	4,300 Added 1.19%	364,800 $10.6 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $745 - $1,446	46 Added 0.01%	360,500 $10.9 Million
Q3 2020 Nov 16, 2020	BUY	$15.59 - $19.97 $47,471 - $60,808	3,045 Added 0.85%	360,454 $5.74 Million
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $75,518 - $148,072	6,309 Added 1.8%	357,409 $7.06 Million
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $4.41 Million - $5.83 Million	351,100 New	351,100 $5.14 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.